Terms: = Leukemia AND IGL
71 results:
1. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
[TBL] [Abstract] [Full Text] [Related]
2. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
[TBL] [Abstract] [Full Text] [Related]
3. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
[TBL] [Abstract] [Full Text] [Related]
4. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
[TBL] [Abstract] [Full Text] [Related]
5. Lineage Switch in an Infant B-Lymphoblastic leukemia With t(1;11)(p32;q23);
Du J; Chisholm KM; Tsuchiya K; Leger K; Lee BM; Rutledge JC; Paschal CR; Summers C; Xu M
Pediatr Dev Pathol; 2021; 24(4):378-382. PubMed ID: 33749383
[TBL] [Abstract] [Full Text] [Related]
6. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract] [Full Text] [Related]
7. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
[TBL] [Abstract] [Full Text] [Related]
8. Expression Cloning of Antibodies from Single Human B Cells.
Wardemann H; Busse CE
Methods Mol Biol; 2019; 1956():105-125. PubMed ID: 30779032
[TBL] [Abstract] [Full Text] [Related]
9.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract] [Full Text] [Related]
10. Primary Nonsecretory Plasma Cell leukemia With Multiple Chromosomal Abnormalities: A Case Report.
Nakayama S; Oda T; Minabe S; Bamba Y; Ukawa H; Sato R; Kawabata M; Horiuchi T; Watanabe J; Kimura F; Shimazaki H; Ogata S; Nakanishi K
Arch Iran Med; 2018 Jan; 21(1):41-43. PubMed ID: 29664669
[TBL] [Abstract] [Full Text] [Related]
11. Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.
Meyer JA; Zhou D; Mason CC; Downie JM; Rodic V; Abromowitch M; Wistinghausen B; Termuhlen AM; Angiolillo AL; Perkins SL; Lones MA; Barnette P; Schiffman JD; Miles RR
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957801
[TBL] [Abstract] [Full Text] [Related]
12. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.
Van Roosbroeck K; Ferreiro JF; Tousseyn T; van der Krogt JA; Michaux L; Pienkowska-Grela B; Theate I; De Paepe P; Dierickx D; Doyen C; Put N; Cools J; Vandenberghe P; Wlodarska I
Genes Chromosomes Cancer; 2016 May; 55(5):428-41. PubMed ID: 26850007
[TBL] [Abstract] [Full Text] [Related]
13. Invivoscribe BIOMED-2 primer mixes in B-cell immunoglobulin gene rearrangement studies: experience of a molecular diagnostics laboratory in a major tertiary care center.
Abbas F; Yazbek SN; Shammaa D; Hoteit R; Fermanian P; Mahfouz R
Genet Test Mol Biomarkers; 2014 Dec; 18(12):787-90. PubMed ID: 25299065
[TBL] [Abstract] [Full Text] [Related]
14. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
Affer M; Chesi M; Chen WG; Keats JJ; Demchenko YN; Roschke AV; Van Wier S; Fonseca R; Bergsagel PL; Kuehl WM
Leukemia; 2014 Aug; 28(8):1725-1735. PubMed ID: 24518206
[TBL] [Abstract] [Full Text] [Related]
15. BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.
Rouhigharabaei L; Ferreiro JF; Put N; Michaux L; Tousseyn T; Lefebvre C; Gardiner A; De Kelver W; Demuynck H; Verschuere J; Théate I; Vicente C; Vandenberghe P; Cools J; Wlodarska I
Genes Chromosomes Cancer; 2013 Oct; 52(10):928-44. PubMed ID: 23873701
[TBL] [Abstract] [Full Text] [Related]
16. The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus.
Mraz M; Stano Kozubik K; Plevova K; Musilova K; Tichy B; Borsky M; Kuglik P; Doubek M; Brychtova Y; Mayer J; Pospisilova S
Leuk Res; 2013 Jul; 37(7):802-8. PubMed ID: 23608880
[TBL] [Abstract] [Full Text] [Related]
17. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
[TBL] [Abstract] [Full Text] [Related]
18. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.
Onozawa M; Aplan PD
Genes Chromosomes Cancer; 2012 Jun; 51(6):525-35. PubMed ID: 22334400
[TBL] [Abstract] [Full Text] [Related]
19. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract] [Full Text] [Related]
20. Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.
Ghia EM; Widhopf GF; Rassenti LZ; Kipps TJ
J Immunol; 2011 Jun; 186(11):6338-44. PubMed ID: 21525382
[TBL] [Abstract] [Full Text] [Related]
[Next]
